Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
U.S. reports 30,000 daily coronavirus cases, highest number since May 1
PUBLISHED SAT, JUN 20 2020 4:41 PM EDT
UPDATED 12 MIN AGO
https://www.cnbc.com/2020/06/20/us-reports-his-number-of-daily-coronavirus-cases-since-may-1.html
Trump campaign members test positive for the coronavirus ahead of rally
The news comes as Trump, the White House and the president's re-election campaign organization have been criticized for hosting an event in an enclosed, 19,000-seat arena in Tulsa.
https://www.nbcnews.com/politics/donald-trump/6-trump-campaign-members-tulsa-test-positive-coronavirus-ahead-rally-n1231647
BRAZILIAN COVID-19 CASES HAVE SHARPLY INCREASED. I WROTE MONTHS EARLIER THAT THIS WOULD BE THE CASE BETWEEN THE SHIFT OF CLIMATE TO THE SOUTHERN HEMISPHERE - - IF THE COLDER CLIMATE PRESUMED TO BE AN INFLUENCING FACTOR. BUT I ALSO WROTE MONTHS EARLIER THAT THE WARMER CLIMATES WOULD NOT CURTAIL OR REDUCE INFECTIOUS VIRULENCE. TO CONFIRM THAT, LOOK AT FLORIDA, CALIFORNIA, ARIZONA, TEXAS, THE MID EAST. ALL EVIDENCE POINTS TO A RELENTLESS COVID-19 VIRUS THAT IS PROGRESSIVELY OUT OF CONTROL. THIS IS NOW A SCIENTIFIC FACT. AND PHASE 2 WILL LEAD TO CATASTROPHE, AS WE ARE ALREADY OBSERVING RECORD SINGLE DAY COVID-19 INFECTIONS. IF WE WERE TO BLAME CHINA, KNOWING ABOUT THE INFECTIONS, NOW WE HAVE NO EXCUSE AS WE ARE KNOWINGLY SPREADING THE INFECTIONS WITH DELIBERATE NEGLIGENCE AND IGNORANCE. THE LEGAL DOCTRINE THAT APPLIES IS “RES IPSA LOQUITOR.” GOVERNMENTS ARE NOW PLAYING WITH FIRE. AND THEY ALL KNOW WHAT IS GOING TO HAPPEN, REPEATEDLY. I REPEAT, WE HAVE RECORD BREAKING ONE DAY INFECTIONS IN VARIOUS AMERICAN STATES TODAY AND YESTERDAY. TOMORROW INTO NEXT WEEK WILL BE WORSE, IF THIS PATTERN CONTINUES.
30/30 results are in shareholder’s interests. BUT FROM BERMAN’S and THE BIO’s STANDPOINT IS TO SATISFY THE FDA’s INTERESTS, THAT TRANSLATES TO SHAREHOLDERS, RESPECTIVELY. THE PATENT AND THE TEST DATA CONFIRM THE ACCURATE TEST FUNCTIONALITY. OTHERWISE, A PATENT WOULD BE USELESS, IF PROTECTING SOMETHING THAT DOESEN’T WORK. JUST GET READY FOR THE ROCKET RIDE. DECN HAS MADE A VERY POWERFULLY, PERFECTED TEST METHOD THAT IS ALSO GOING TO BE USED FOR OTHER VIRUSES TOO. THE PATENT SPEAKS VOLUMES FOR SOLVING THE BLOOD HEMATOCRIT HINDRANCE. THAT ALSO TRANSLATES TO THE OTHER TESTS THAT DECN IS GOING TO PRODUCE. THE PATENTED TECHNOLOGY IS MULTI-FUNCTIONAL. THERE WILL BE A ROCKET RIDE. COVID-19 INFECTIONS ARE ALSO BEGINNING TO INCREASE AGAIN, AS SOON AS PEOPLE EASED THE RESTRICTIONS. THIS IS GOING TO INCREASE EXPONENTIALLY. CROSS CONTAMINATION AND CROSS TRANSMISSION HAS OCCURRED. THIS WILL WORSEN.
There will be a very sharp increase in new COVID-19 cases. My observations of the immediate increases during lock down relaxing, compared to the initial outbreak suggests continual, high infection transmission and reporting. We are going right back to where it started. And China cannot be blamed for any part of any of this.
412 new coronavirus cases and four more deaths reported for the San Antonio area
“The numbers continue to rise exponentially,” Mayor Ron Nirenberg said during a televised briefing with Bexar County Judge Nelson Wolff. “At no other point during this public health crisis have we seen numbers like this.”
https://www.mysanantonio.com/news/local/article/San-Antonio-COVID-cases-rise-exponentially-15353497.php
WHO warns of ‘new and dangerous phase’ as coronavirus accelerates; Americas now hardest hit
The World Health Organization warned Friday that “the world is in a new and dangerous phase” as the global pandemic accelerates. The world recorded about 150,000 new cases on Thursday, the largest rise yet in a single day, according to the WHO. Nearly half of these infections were in the Americas, as new cases continue to surge in the United States, Brazil and across Latin America.
https://www.washingtonpost.com/nation/2020/06/19/coronavirus-live-updates-us/
IMPORTANT READ: An electrochemical immunosensor for the corona virus associated with the Middle East respiratory syndrome using an array of gold nanoparticle-modified carbon electrodes
To the best of our knowledge, until now, no electrochemical biosensors have been reported for the detection of MERS-CoV. In this work, a novel competitive electrochemical immunosensor for MERS-CoV virus detection is developed.
https://link.springer.com/article/10.1007/s00604-019-3345-5
987 cases in SC, single day record
https://amp.thestate.com/news/coronavirus/article243627762.html
The military’s rate of new coronavirus cases doubled this week
https://www.militarytimes.com/news/your-military/2020/06/19/the-militarys-rate-of-new-coronavirus-cases-doubled-this-week/
Florida Reports Highest New Coronavirus Cases at 3,822
The Florida Department of Health reported 3,822 new coronavirus cases on Friday, putting the state at 89,748 total confirmed cases
https://people.com/health/florida-reports-its-highest-single-day-new-coronavirus-cases/
The World Health Organization warned Friday that “the world is in a new and dangerous phase” as the global pandemic accelerates. The world recorded about 150,000 new cases on Thursday, the largest rise yet in a single day, according to the WHO. More than 8.5 million coronavirus cases and at least 454,000 deaths have been reported worldwide.
The CDC said Thursday that the U.S. death toll from the coronavirus could rise to as high as 145,000 by July 11, meaning as many as 26,000 Americans could die in the next few weeks.
Trump said the NFL is “planning a very safe and controlled opening” and took a swipe at top federal infectious-disease expert Anthony S. Fauci for expressing skepticism that football could safely be played this year. In a recent interview with the Wall Street Journal, Trump called coronavirus testing “overrated.”
AMC Theaters on Friday reversed course and announced it will require guests to wear masks. The movie theater chain’s president had drawn backlash a day earlier for saying moviegoers wouldn’t be mandated to wear masks because “we did not want to be drawn into a political controversy.”
Both Washington, D.C. and New York City will enter Phase 2 of coronavirus recovery on Monday, according to announcements Friday by D.C. Mayor Muriel E. Bowser (D) and New York Gov. Andrew M. Cuomo (D).
On Friday, Britain lowered its coronavirus threat level from four to three, following advice from chief medical officers and the country’s Joint Biosecurity Center. Ethnic minorities in Britain may get priority for accessing a coronavirus vaccine, the country’s health secretary said Thursday.
https://www.washingtonpost.com/nation/2020/06/19/coronavirus-live-updates-us/?outputType=amp
BRIEF IN SUPPORT TO TERMINATE TRADING SUSPENSION
https://www.sec.gov/litigation/apdocuments/3-19788-event-2020-06-17-petitioner-brief-in-support.pdf
Trump says coronavirus is 'dying out;' Dr. Sanjay Gupta says the virus is not dying
https://www.cnn.com/2020/06/18/media/donald-trump-coronavirus-reliable-sources/index.html
SEC IMPLICATED ITSELF WITH THE FOLLOWING SUMMATION, BELOW.
1. DECN announces that it is jumping into screening and testing for COVID-19 using the same technology first implemented in its diabetes test kit;
FACT
2. DECN makes first year product forecast of 420 million kit;
FACT
3. DECN announces that its “Swift Kit” will be offered to commercial labs and religious groups as 12 month forecast is raised to 525 million kits;
FACT
4. DECN announces FDA guidance allows for near immediate distribution of kits prior to Emergency Waiver Grants;
ABSOLUTE FACT: “In addition, this guidance describes a policy for commercial manufacturers to more rapidly distribute their SARS-CoV-2 diagnostic tests to laboratories for specimen testing after validation, while an EUA is being prepared for submission to FDA. This policy remains unchanged from the second publication of this guidance on March 16, 2020, though some process updates and clarification have been made as discussed further below.
As outlined in the May 4, 2020 update, FDA does not intend to object as described below where commercial manufacturers develop and distribute their serology tests after validation, for a limited period of time, while an EUA is being prepared for submission to FDA. Appendices with templates for such submissions have been added to facilitate and streamline the EUA process.
5. DECN announces that it received a “Pre-EUA Acknowledgement Letter.”
I declare under penalty of perjury under the laws of the United States of America that the foregoing is true and correct. ABSOLUTE FACT. CAN ALSO BE VERIFIED WITH CORRESPONDING SERIAL NUMBERS.
Dated: May 20, 2020
___________________________________ Carlisle Perkins, Senior Counsel
Securities & Exchange Commission Division of Enforcement
$$$$$$$$$$$$$$$$$$, DEFINITELY!!!!!!
SEC, Carlisle Perkins, Is Incompetent. PROOF: READ EVERYTHING. https://www.sec.gov/litigation/apdocuments/3-19788-event-2020-05-20-information-before-the-commission-at-the-time-of-the-trading-suspension-and-declaration-of-carlisle-e-perkins.pdf
1. DECN announces that it is jumping into screening and testing for COVID-19 using the same technology first implemented in its diabetes test kit;
2. DECN makes first year product forecast of 420 million kit;
3. DECN announces that its “Swift Kit” will be offered to commercial labs and religious groups as 12 month forecast is raised to 525 million kits;
4. DECN announces FDA guidance allows for near immediate distribution of kits prior to Emergency Waiver Grants;
5. DECN announces that it received a “Pre-EUA Acknowledgement Letter.”
I declare under penalty of perjury under the laws of the United States of America that the foregoing is true and correct.
Dated: May 20, 2020
___________________________________ Carlisle Perkins, Senior Counsel
Securities & Exchange Commission Division of Enforcement
In addition, this guidance describes a policy for commercial manufacturers to more rapidly distribute their SARS-CoV-2 diagnostic tests to laboratories for specimen testing after validation, while an EUA is being prepared for submission to FDA. This policy remains unchanged from the second publication of this guidance on March 16, 2020, though some process updates and clarification have been made as discussed further below.
As outlined in the May 4, 2020 update, FDA does not intend to object as described below where commercial manufacturers develop and distribute their serology tests after validation, for a limited period of time, while an EUA is being prepared for submission to FDA. Appendices with templates for such submissions have been added to facilitate and streamline the EUA process.
The policy for serological tests developed and used by laboratories that are certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing has not changed from the March 16, 2020 guidance, though FDA continues to encourage such laboratories to submit EUAs for their laboratory developed tests.
In the context of a public health emergency involving pandemic infectious disease, it is critically important that tests are validated because false results not only can negatively impact the individual patient but also can have broad public health impact. In this guidance, FDA provides recommendations regarding validation of COVID-19 tests based on the available information.
https://www.fda.gov/media/135659/download
SEC LINK: Carlisle Perkins, Senior Counsel Securities & Exchange Commission Division of Enforcement
Carlisle Perkins is Incompetent and compulsive. Allegations in complaint don’t make any sense, and are fully contradicted and refuted. COMPARE WITH MY LAST POST.
https://www.sec.gov/litigation/apdocuments/3-19788-event-2020-05-20-information-before-the-commission-at-the-time-of-the-trading-suspension-and-declaration-of-carlisle-e-perkins.pdf
PENCE IS RIGHT. Second wave fears are overblown. The reality is that the first wave is not over and never will be over.
Nine states hit record highs for covid-19 cases as Pence calls fear of second wave ‘overblown’
A host of states in the western and southern United States have seen coronavirus cases climb in recent days, raising fears of a new wave, as infections dwindle in other states that were initially hit harder.
https://www.washingtonpost.com/nation/2020/06/17/coronavirus-live-updates-us/
Grim India record with 2,000 dead in one day: Live updates
Experts express concern over accuracy of infection and death data in India as testing capacity remains limited.
https://www.aljazeera.com/news/2020/06/brazil-coronavirus-cases-hit-daily-record-live-updates-200617002826411.html
Pink sheet-listed companies have no requirement to be listed. All a company needs to do to get listed on the pink sheets is submit a form, entitled Form 211, with the OTC Compliance Unit. Usually, this is done on behalf of a company by a market maker. The form must have current financial information.
https://www.investopedia.com/articles/fundamental-analysis/08/pink-sheets-ottcb.asp
VERY CONFIDENT!!! “The company expects its kit availability schedule to remain unchanged, with delivery outside the US commencing as early as during the summer months, and within the US and North American markets shortly after FDA authorization.”
Somebody knows something big brewing. We are going all out. We have a NEW PATENTED built in technology that eliminates blood HCT LYSIS, AMENDMENTS TO THE FDA APPLICATION, AMENDMENTS TO THE GENVIRO PATENT AND FINALIZED DISTRIBUTION AGREEMENTS IN: “We have recently received a written commitment for the distribution of our GenViro! Swift Kits from a previously referenced distributor who will represent the product in India, Singapore, Malaysia and Indonesia, and in recent negotiations we have come to an agreement on distribution of GenViro! Swift kits in Thailand, Vietnam, Nepal, Bangladesh, Sri Lanka, and Australia. We will discuss this in greater length is subsequent announcements."
https://finance.yahoo.com/news/decn-files-provisional-patent-genviro-142000019.html
NEW DISTRIBUTION AGREEMENTS REACHED “We have recently received a written commitment for the distribution of our GenViro! Swift Kits from a previously referenced distributor who will represent the product in India, Singapore, Malaysia and Indonesia, and in recent negotiations we have come to an agreement on distribution of GenViro! Swift kits in Thailand, Vietnam, Nepal, Bangladesh, Sri Lanka, and Australia. We will discuss this in greater length is subsequent announcements."
DECN ELIMINATED THE BLOOD HEMATOCRIT LYSIS INTERFERENCE WITH A PATENTED TECHNOLOGY, INCORPORATED INTO THE GENVIRO. THAT IS A HUGE BREAKTHROUGH.
1) the exclusion of the need for a chemical lysing solution and its intricacies, 2) mathematically correct for the hematocrit effect, where high and low HCT has the potential to interfere with electronic readings, and 3) further lower the time required for a completed Covid-19 test result by an anticipated 30%.
GREAT NEWS!!! LOS ANGELES, CA / ACCESSWIRE / June 17, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc., today announced it has filed a provisional patent for its Genviro! Swift Professional product titled, "Method and Apparatus for Swift Determination of the Covid-19 Virus." In so doing, the company is unveiling its Hematocrit adjustment feature, initially developed for its GenUltimate TBG system. When incorporated into the GenViro! System an expected 30% improvement in result reporting time from the current testing time of :15 seconds will be available to the administrator of the test, while at the same time adjusting for issues involving an abundance of or insufficiency of red blood cells in a patient blood sample. The company will document this improvement in its previously announced FDA EUA Addendum II filing for PEUA200232. Pharma Tech Solutions first submitted its GenViro! professional use device to the FDA on April 3, 2020.
Specifically, the addition of the Hematocrit (HCT) adjustment feature will be used during each testing phase of the GenViro! test kit, to adjust for an abundance of or insufficiency of red blood cells in a patient sample. The addition of our TBG technology will yield three benefits: 1) the exclusion of the need for a chemical lysing solution and its intricacies, 2) mathematically correct for the hematocrit effect, where high and low HCT has the potential to interfere with electronic readings, and 3) further lower the time required for a completed Covid-19 test result by an anticipated 30%.
NEWS OUT!!!!
DECN Files Provisional Patent For GenViro! Professional COVID-19 :15 Swift Kit, Adds Enhanced Technology To Allow For Even Swifter Results
6/17/20, 10:20 AM
Diabetes May Be Triggered by COVID-19, According to Experts
https://www.newsweek.com/diabetes-triggered-covid-19-experts-1510805
electrochemical immunosensor for corona virus associated with Middle East respiratory syndrome using an gold nanoparticle-modified carbon electrodes
https://link.springer.com/article/10.1007/s00604-019-3345-5
Perspectives of Biosensors POCT Personalized Screening of Coronavirus
https://scholar.google.com/scholar?q=electrochemical+impedance+coronavirus+detection&hl=en&as_sdt=0&as_vis=1&oi=scholart#d=gs_qabs&u=%23p%3DDRGl-uFc6koJ
Pence tries to declare coronavirus over as Trump pushes reopening and campaigning. Pence and Trump are both, two dangerous idiots. https://www.cnn.com/2020/06/16/politics/mike-pence-coronavirus-reopen-campaign/index.html
Coronavirus disease (COVID-19) pandemic
https://www.who.int/
But this historic pandemic is not ending. It is surging. There were 136,000 new infections reported on Sunday, the highest single-day increase since the start of the pandemic.
https://www.washingtonpost.com/world/2020/06/11/coronavirus-pandemic-isnt-ending-its-surging/
THE FDA SERIAL NUMBERS FOR THE GENVIRO PROFESSIONAL AND HOME KITS ARE: PEUA200232, GenViro Covid-19 Screening Kit. We have since submitted a similar, but more complicated application for our individual home testing kit. This new kit has also received an FDA Acknowledgement letter, for device (serial number) PEUA200947. With receipt of the PEUA letters, the FDA discloses that review staff is assigned to the application.
https://www.biospace.com/article/covid-19-15-second-home-testing-genviro-swift-kit-identified-by-largest-cbs-affiliate-in-the-country-as-potential-testing-solution-to-help-get-country-back-to-work/
We Need a Cheap Way to Diagnose Coronavirus
https://hbr.org/2020/02/we-need-a-cheap-way-to-diagnose-coronavirus
LINK: THE MFG
https://www.medica-tradefair.com/vis/v1/en/exhibitors/medcom2019.2615195
Company details:
“We have advanced production lines and technology for the production of top-end blood glucose monitoring systems
(corporate research center)
We have completed production lines for blood glucose monitoring systems for 3 companies
(2013~2015)
We have entered into an agreement with an overseas company for the construction of production lines for blood glucose monitoring systems
(June, 2015)
We have adopted the ISO 15197:2013 requirements that enable us to develop new technologies for the upgrade of measurement accuracy.
We have developed technologies for vitamin D testing system and next-generation bio sensors.”
Cases Still Rising - - OVER 200,000 in a day.
https://www.worldometers.info/coronavirus/
DECN WILL NOT BE SUSPENDED. THE SEC NEVER CONDUCTED A FULL AND IMPARTIAL INVESTIGATION INTO EXISTING FACTS. DECN’S EUA APPLICATION WAS ALREADY SUBMITTED AND THE GENVIRO WAS UNDER DEVELOPMENT. THE SALES FORECASTS WERE LEGAL APPRAISALS OF MARKETABILITY. AND THE GENVIRO RESULT RENDERING TIME PERIOD WAS LEGIT. THE UNLYSED BLOOD SAMPLES TESTED 99-100% ACCURATE. AND THE VIRUS LADEN BLOOD, AFTER LYSIS WILL RENDER 99-100% SENSITIVITY FOR THE VIRUS, AFTER LYSIS.
Model projects 200,000 people in the US could die from Covid-19 by October. Why that estimate might be low
https://www.cnn.com/2020/06/16/health/us-coronavirus-tuesday/index.html
Don’t forget where CODX is now. We have one of the most accurate, fastest and most efficient virus testing methods in the world evolving towards a brand new breakthrough revolution. We are on the ground floor of this phenomenal technology that is sought after by many of the world’s leading scientists in many disciplines. DECN WILL BE A LEADER IN THE ELECTROCHEMICAL IMPEDANCE DIAGNOSTICS FIELD. GET READY FOR IMMINENTLY REWARDING RESULTS. ALL OF THE SCIENTIFIC DATA POINTS TO A HUGE BREAKTHROUGH. THE APPLICATIONS ARE ENDLESS.
https://www.google.com/search?client=safari&channel=iphone_bm&source=hp&ei=evvoXrSXOeSQggexr4XwBw&q=ELECTROCHEMICAL+IMPEDANCE+VIRUS+DETECTION+&oq=ELECTROCHEMICAL+IMPEDANCE+VIRUS+DETECTION+&gs_lcp=ChFtb2JpbGUtZ3dzLXdpei1ocBAMMgUIIRCgATIFCCEQoAEyBQghEKABMgUIIRCrAjIFCCEQqwIyCAghEBYQHRAeOgIIKToFCCkQoAE6BQgAELEDOgIIADoFCC4QsQM6BQgAEIMBOggILhCxAxCTAjoCCC46BggAEBYQHlDUXFjd6wFgqv0BaAFwAHgAgAGiAogBtiSSAQcyNS4xNi4ymAEAoAEBsAEN&sclient=mobile-gws-wiz-hp
https://www.google.com/search?client=safari&channel=iphone_bm&ei=nfvoXsKtD-uuwbkPw5qk0Ao&q=ELECTROCHEMICAL+IMPEDANCE+cancer+detection&oq=ELECTROCHEMICAL+IMPEDANCE+cancer+detection&gs_lcp=ChNtb2JpbGUtZ3dzLXdpei1zZXJwEAwyBQghEKsCMggIIRAWEB0QHjoECAAQRzoCCCk6BggAEBYQHjoCCAA6AgguOgUIIRCgAToHCCEQChCgAVCOogZYnZQHYMqdB2gCcAJ4AIABtwOIAeMrkgEKMy4yMi4zLjMuMpgBAKABAQ&sclient=mobile-gws-wiz-serp